China approves third COVID-19 vaccine for clinical trials
A total of 96 persons in three age groups have received the vaccine in the first phase of clinical trial as of April 23
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Wuhan Institute of Biological Products
China approves two experimental coronavirus vaccines to enter clinical trials
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech , and by the Wuhan Institute of…